Algorae Pharmaceuticals Ltd (1AI)

Sydney
Currency in AUD
0.006
-0.001(0.00%)
Closed
1AI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.0060.007
52 wk Range
0.0050.013
Key Statistics
Edit
Bid/Ask
0.006 / 0.007
Prev. Close
0.007
Open
0.007
Day's Range
0.006-0.007
52 wk Range
0.005-0.013
Volume
501.43K
Average Volume (3m)
1.23M
1-Year Change
-30%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1AI Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations
Show more

Algorae Pharmaceuticals Ltd Company Profile

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company’s product pipeline includes AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient for the of treatment for dementia, including Alzheimer’s disease; NTCELL, an alginate coated capsule to target the treatment of Parkinson’s disease; and AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient to treat cardiovascular disease, including hypertension. It is also developing AlgaraeOS in partnership with the University of New South Wales, an artificial intelligence platform for biopharmaceutical prediction of both fixed dose combination drug targets and repurposed drug targets agnostic to medical indication. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. Algorae Pharmaceuticals Limited was founded in 1987 and is based in Melbourne, Australia.

Compare 1AI to Peers and Sector

Metrics to compare
1AI
Peers
Sector
Relationship
P/E Ratio
−5.6x−3.4x−0.6x
PEG Ratio
−0.260.000.00
Price/Book
3.9x2.5x2.6x
Price / LTM Sales
94.3x9.8x3.1x
Upside (Analyst Target)
-264.2%54.8%
Fair Value Upside
Unlock3.0%7.9%Unlock

Earnings

Latest Release
Feb 27, 2023
EPS / Forecast
-- / --
Revenue / Forecast
8.49K / --
EPS Revisions
Last 90 days

FAQ

What Is the Algorae Pharmaceuticals (1AI) Stock Price Today?

The Algorae Pharmaceuticals stock price today is 0.006

What Stock Exchange Does Algorae Pharmaceuticals Trade On?

Algorae Pharmaceuticals is listed and trades on the Sydney stock exchange.

What Is the Stock Symbol for Algorae Pharmaceuticals?

The stock symbol for Algorae Pharmaceuticals is "1AI."

What Is the Algorae Pharmaceuticals Market Cap?

As of today, Algorae Pharmaceuticals market cap is 11.81M.

What is Algorae Pharmaceuticals Earnings Per Share?

The Algorae Pharmaceuticals EPS is -0.001.

From a Technical Analysis Perspective, Is 1AI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.